Xilio Therapeutics Appoints Yuan Xu, Ph.D., to its Board of Directors
Xilio Therapeutics Announces Initiation of Patient Dosing in Phase 1/2[...]
01/24/2022 | Press release | Distributed by Public on 01/24/2022 16:08
Please select the service you want to use:
Smartlinks | First Foundation Inc. | News | Health | Local News | Business and Economy | Finance | Stock Markets | Security Markets | Fixed Income | Bonds | Stock Markets | Security Markets | Company News | Top Company News | Corporate Debt | Corporate Bonds | Financial Services | Banking | Professional and Business Services | Legal Services | Public Companies | Banks | Börse Frankfurt | NYSE American | NYSE ARCA Equities | Nasdaq Global Market | BZX Exchange | BYX Exchange | EDGA Exchange | EDGX Exchange | NYSE National | Nasdaq BX | Nasdaq PSX | FINRA Alternative Display Facility (ADF) | NYSE Chicago
Back
Copyright ©2006-2022 Public Technologies Inc. | Privacy Policy | Terms of Use | Contact